Tuesday, May 5, 2026

From Pyongyang with Trash: North Korea’s Balloon Provocation Continues!

North Korea has initiated yet another balloon campaign to send propaganda and waste to South Korea just three days after the last incident.

Apple’s $3 Trillion Status Crashes After Trump Warning

Trump's tariff threat leads to a drop in Apple's stock, compounding challenges like declining Chinese sales and talent loss.

Actress Kim Sae Ron’s Heartbreaking Fight to Rebuild Her Career Before Her Passing

Kim Sae Ron struggled for a comeback after a drunk-driving incident, facing job rejections and online harassment before her tragic death.

Tag: Nesuparib

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.